Enterohemorrhagic Escherichia coli (EHEC) in pediatric hemolytic-uremic syndrome: A prospective study in Germany and Austria

Infection

Volumn 27, Issue 6, 1999, Pages 341-347

  Verweyen, Hege Maria ^a   Karch, H ^b   Allerberger, F ^c   Zimmerhackl, L B ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Institute for Hygiene and Microbiology   (Germany)

^c Institute for Hygiene and Social Medicine   (Austria)

Author keywords

Diarrhea; E. coli; Enterohemorrhagic; Epidemiology; Hemolytic uremic syndrome; Renal insufficiency; Serology

Indexed keywords

ANTIBODY; ESCHERICHIA COLI LIPOPOLYSACCHARIDE;

ANURIA; ARTICLE; AUSTRIA; BACTERIUM ISOLATION; CHILD; CONTROLLED STUDY; DIALYSIS; DIARRHEA; ENTEROBACTER INFECTION; ENVIRONMENTAL FACTOR; ESCHERICHIA COLI; FATALITY; FECES CULTURE; FEMALE; GERMANY; HEMOLYTIC UREMIC SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGICAL COMPLICATION; OLIGURIA; SEROLOGY; SEROTYPE;

ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; AUSTRIA; CHILD; CHILD, PRESCHOOL; ESCHERICHIA COLI; ESCHERICHIA COLI O157; FECES; FEMALE; GERMANY; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; SEROTYPING; TIME FACTORS;

EID: 0032755791     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s150100050040     Document Type: Article

References (35)

1. Pistor K: Monatsschr Kinderheilkd 1995; 143: 1039-1040.
2. Karmali MA, Steele BT, Petric M, Lim C: Sporadic cases of haemolytic-uremic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli. Lancet 1983; 619-620.
3. Siegler R: The hemolytic uremic syndrome. Pediatr Clin North Am 1995; 42: 1505-1529.
4. Ludwig K, Bitzan M, Zimmermann S, Kloth M, Ruder H, Müller-Wiefel DE: Immune response to non-O157 vero toxin-producing Escherichia coli in patients with hemolytic uremic syndrome. J Infect Dis 1996; 174: 1028-1039.
5. Tarr PI, Fouser LS, Stapleton AE, Wilson RA, Kim HH, Vary JC, Clausen CR: Hemolytic-Uremic Syndrome in a six-year-old girl after an urinary tract infection with Shiga-Toxin-producing Escherichia coli O103:H2. N Engl J Med 1996; 335: 635-638.
6. Caprioli A, Luzzi I, Rosmini F, Resti C, Edefonti A, Perfumo F: Communitywide outbreak of hemolytic-uremic syndrome associated with non-O157 verocytotoxin-producing Escherichia coli. J Infect Dis 1994; 169: 208-211.
7. Bourdaillez B, Berquin P, Mariani-Kurdjian P, Bef D, Cuvelier B, Capek J: Possible person-to-person transmission of Escherichia coli O111-associated hemolytic uremic syndrome. Pediatr Nephrol 1997; 11: 36-39.
8. Banatvala N, Debeukelaer MM, Griffin PM, Barrett TJ, Greene KD, Green JH, Wells JG: Shiga-like toxin-producing Escherichia coli O111 and associated hemolytic-uremic syndrome: a family outbreak. Pediatr Infect Dis J 1996; 15: 1008-1011.
9. Nataro JP, Kaper JB: Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998; 11: 142-201.
10. Beutin L, Zimmermann S, Gleier K: Human infections with Shiga toxin-producing Escherichia coli other than serogroup O157 in Germany. Emerg Infect Dis 1998; 4: 635-639.
11. Schmidt H, Rüssmann H, Schwarzkopf A, Aleksic S, Heesemann J, Karch H: Prevalence of attaching and effacing Escherichia coli in stool samples from patients and controls. Int J Med Microbiol Virol Parasitol Infect Dis 1994; 281: 201-221.
12. Karch H, Janetzki-Mittmann C, Aleksic S, Datz M: Isolation of enterohemorrhagic Escherichia coli O157 strains from patients with hemolytic uremic syndrome by using immunomagnetic separation, DNA-based methods and direct culture. J Clin Microbiol 1996; 516-519.
13. Schmidt H, Karch H, Beutin L: The large-sized plasmids of enterohemorrhagic Escherichia coli O157 strains encode hemolysins which are presumably members of the E. coli alpha-hemolysin family. FEMS Microbiol Lett 1994; 117: 189-196.
14. Karch H, Böhm H, Schmidt H, Gunzer F, Aleksic S, Heesemann J: Clonal structure and pathogenicity of Shiga-like toxin-producing, sorbitol-fermenting Escherichia coli O157:H. J Clin Micro-biol 1993; 31: 1200-1205.
15. Bockemühl J, Aleksic S, Karch H: Serological and biochemical properties of Shiga-like toxin (verocytotoxin)-producing strains of Escherichia coli, other than O-group 157, from patients in Germany. Zentralbl Bakteriol 1992; 276: 189-195.
16. Gentry MK, Dalrymple JM: Quantitative microtiter cytotoxicity assay for Shigella toxin. J Clin Microbiol 1980; 12: 361-366.
17. Bitzan M, Ludwig K, Klemt M, König H, Büren J, Müller-Wiefel DE: The role of Escherichia coli O157 infections in the classical (enteropathic) haemolytic uremic syndrome: results of a Central European, multicentre study. Epidemiol Infect 1993; 110: 183-196.
18. Kar van de NCAJ, Roelfs HGR, Muytjens HL, Tolboom JMJ, Roth B, Proesmans W, Reitsma-Bierens WCC, Wolff ED, Karmali MA, Chart H, Monnens LAH: Verocytotoxin-producing Escherichia coli infection in hemolytic uremic syndrome in part of Western Europe. Eur J Pediatr 1996; 155: 592-596.
19. Huppertz HI, Busch D, Schmidt H, Aleksic S, Karch H: Diarrhea in young children associated with Escherichia coli non-O157 organisms that produce Shiga-like toxin. J Pediatr 1996; 128: 341-346.
20. Tarr PI: Escherichia coli O157:H7: clinical, diagnostic, and epidemiological aspects of human infection. Clin Infect Dis 1995; 20: 1-10.
21. Bégué RE, Neill MA, Papa EF, Dennehy PH: A prospective study of Shiga-like toxin-associated diarrhea in a pediatric population. J Pediatr Gastroenterol Nutr 1994; 19: 164-169.
22. Lopez EL, Diaz M, Grinstein S: Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins. J Infect Dis 1989; 160: 469-475.
23. Bitzan M, Moebius E, Ludwig K, Müller-Wiefel DE, Heesemann J, Karch H: High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome. J Pediatr 1991; 119: 380-385.
24. Caprioli A, Luzzi I, Rosmini F, Pasquini P, Cirrincione R, Gianviti A, Matteucci MC, Rizzoni G: Hemolytic-uremic syndrome and vero cytotoxin-producing Escherichia coli infection in Italy. J Infect Dis 1992; 166: 154-158.
25. Gianviti A, Rosmini F, Caprioli A: Hemolytic uremic syndrome in childhood: surveillance and case-control studies in Italy. Pediatr Nephrol 1994; 8: 705-709.
26. Siegler RL, Pavia AT, Hansen FL, Christofferson RD, Cook JB: Atypical hemolytic-uremic syndrome: a comparison with post-diarrheal disease. J Pediatr 1996; 128: 505-511.
27. Rüssmann H, Kothe E, Schmidt H, Franke S, Harmsen D, Caprioli A, Karch H: Genotyping of Shiga-like toxin genes in non-O157 Escherichia coli strains associated with haemolytic uraemic syndrome. J Med Microbiol 1995; 42: 404-410.
28. Ojeda A, Prado V, Martinez J, Arellano C, Borczyk A, Johnson W, Lior H, Levine MM: Sorbitol-negative phenotype among Escherichia coli strains of different serotypes and from different sources. J Clin Microbiol 1995; 33: 2199-2201.
29. Tarr PI, Neill MA: Perspective: the problem of non-O157:H7 Shiga toxin (verocytotoxin)-producing Escherichia coli. J Infect Dis 1996; 174: 1136-1139.
30. Rowe PC, Orrbine E, Lior H, Wells GA, Yetisir E, Clulow M, McLaine PN: Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: results of a Canadian collaborative study. J Pediatr 1998; 13: 777-782.
31. Rowe PC, Orrbine E, Wells GA, McLaine PN: Epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988. J Pediatr 1991; 119: 218-224.
32. Kelles A, Van Dyck M, Proesmans W: Childhood haemolytic uraemic syndrome: long-term outcome and prognostic features. Eur J Pediatr 1994; 153: 38-42.
33. Mizusawa Y, Pitcher LA, Burke JR, Falk MC, Mizushima W: Survey of haemolytic-uraemic syndrome in Queensland 1979-1995. Med J Aust 1996; 165: 188-191.
34. Milford DV, Tylor CM, Guttridge B, Hall SM, Rowe B, Kleanthous H: Haemolytic uraemic syndrome in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part I: Clinical and epidemiological aspects. Arch Dis Child 1990; 65: 716-721.
35. Rahman M, Hossain M: The bimodal mortality pattern of acute renal failure in children. Ren Fail 1993; 15: 55-59.